Trial
NCT01252238
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
—
Condition
Insulin Sensitivity
Intervention
Aliskiren
Why stopped
Study sponsor terminated study due to AE's reported with valsartan and aliskiren
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-13